• HLA typing, DR/DQ, Single or Multi Antigen
  • Albumin, 24 Hour, Urine
  • Cardio Pharmacogenetics (PGx) Gene Variation Panel
  • NTRK Gene Fusion Panel (NTRK1, NTRK2, and NTRK3), Solid Tumors
  • Mycoplasma pneumoniae Antibody, CF (CSF)
  • Francisella tularensis Antibody, IgG, IgM
  • PCA3/KLK3 (prostate cancer antigen 3/kallikrein-related peptidase 3) ratio
  • Porphyrins, Feces
  • Lipase, Serum
  • Cytochrome P450 2C9 (CYP2C9) Genotyping
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Anaplastic Lymphoma Kinase (ALK) Gene Mutation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Anaplastic Lymphoma Kinase (ALK) Gene Mutation Analysis
Medical Test

Interpretation
Access to Anaplastic Lymphoma Kinase (ALK) Gene Mutation Analysis is restricted.